Our findings reveal an underlying mechanism the HDAC6-mediated deacetylation of TAK1 regulation of sIL-6R release and suggest a promising strategy for inhibiting the development of colon cancer. This evidence concerns the gene HDAC6 and malignant colon neoplasm.